ライフサイエンスコーパス: Cryptosporidium

1 by several species of the protozoan parasite Cryptosporidium.

2 three parasites: Plasmodium, Toxoplasma, and Cryptosporidium.

3 esulting in reduced in vivo efficacy against Cryptosporidium.

4 ot an important predictor of the presence of Cryptosporidium.

5 The PECs were infected with Cryptosporidium.

6 h quantitative polymerase chain reaction for Cryptosporidium.

7 find safe and effective drug candidates for Cryptosporidium.

8 optimized a rapid method to silence genes in Cryptosporidium.

9 hanisms that underlie protective immunity to Cryptosporidium.

10 duced invasion, proliferation, and egress of Cryptosporidium.

11 lic water systems (PWS) in the U.S. consider Cryptosporidium a microbial contaminant of surface water

12 alysis of any transcription factor family in Cryptosporidium, a basal-branching apicomplexan that is

13 Cryptosporidium, a protozoan parasite that infects the g

14 ts/g (about 1 oocyst/g for a pica child) for Cryptosporidium, about 5 MPN/g (about 1 MPN/g for pica)

15 he findings of this study not only validated Cryptosporidium ACS (and related acyl-[acyl-carrier-prot

16 Cryptosporidium ACSs displayed substrate preference towa

17 In this study, we evaluated the anti-Cryptosporidium activity of a novel CDPK1 inhibitor, 129

18 coli (AF, 14.5% [95% CI, 10.2%-22.8%]), and Cryptosporidium (AF, 7.9% [95% CI, 6.2%-9.3%]).

19 Giardia duodenalis, Cryptosporidium, Ancylostoma, Uncinaria, and Toxocara ca

20 n pathogens, such as Plasmodium, Toxoplasma, Cryptosporidium and Babesia species.

21 t of detection (LD), ca. 0.05 raw no's/L for Cryptosporidium and ca. 0.10 raw no's/L for Giardia.

22 alence is estimated to decline by 10.5% with Cryptosporidium and E. coli prevalence increasing by 9.9

23 Through case studies using Cryptosporidium and Escherichia coli, we show that failu

24 We modeled observed Cryptosporidium and Giardia contamination in community p

25 emental Survey (ICR SS) required analysis of Cryptosporidium and Giardia in 10 L surface water sample

26 Data analysis illustrates key features of Cryptosporidium and Giardia in surface water: presence i

27 The data describe Cryptosporidium and Giardia in watersheds nation-wide ov

28 The data and analysis illustrate features of Cryptosporidium and Giardia occurrence in surface water

29 Alcorfix effectively fixed live Cryptosporidium and microsporidia such that morphology a

30 tudying host-parasite interactions involving Cryptosporidium and other intestinal pathogens.

31 gG) and immunoglobulin A (IgA) antibodies to Cryptosporidium and rotavirus, and the lactulose to mann

32 e-phase synchronization was observed between Cryptosporidium and Shigella, Listeria, and Salmonella (

33 rks for Toxoplasma gondii, Neospora caninum, Cryptosporidium and Theileria species, and Babesia bovis

34 ty analysis of protozoan pathogens including Cryptosporidium and/or Giardia at the single (oo)cyst le

35 Detection of Cryptosporidium and/or Giardia in a tubewell was positiv

36 a include detectable parasitic (eg, Giardia, Cryptosporidium) and bacterial (eg, enteroaggregative Es

37 in 23500 for Campylobacter, 1 in 5050000 for Cryptosporidium, and 1 in 118000 for rotavirus.

38 y to Mycobacterium tuberculosis, Salmonella, Cryptosporidium, and cytomegalovirus.

39 r veterinary importance, such as Plasmodium, Cryptosporidium, and Eimeria.

40 6, and 9 parasites per reaction for Giardia, Cryptosporidium, and Entamoeba parasites, respectively.

41 opies per reaction of the synthetic Giardia, Cryptosporidium, and Entamoeba targets, respectively (ro

42 to detect the presence of DNA from Giardia, Cryptosporidium, and Entamoeba.

43 ny of the diarrhea-causing protozoa Giardia, Cryptosporidium, and Entamoeba.

44 We used reference pathogens Campylobacter, Cryptosporidium, and rotavirus as conservative risk prox

45 Rotavirus, norovirus genogroup II, Cryptosporidium, and Shigella species/enteroinvasive Esc

46 ites include those of the genera Plasmodium, Cryptosporidium, and Toxoplasma and those of the relativ

47 ion within 50 m and the sheep population for Cryptosporidium, and with the village illiteracy rate fo

48 The protozoan parasites of the genus Cryptosporidium are increasingly recognized to be respon

49 e countries have confirmed the importance of cryptosporidium as a cause of diarrhoea and childhood ma

50 ldren have identified the protozoan parasite Cryptosporidium as the second most important diarrhoeal

51 The RPA-based Cryptosporidium assay (RPAC assay) was developed and opt

52 resent data that suggest these cells support Cryptosporidium better than existing cell lines.

53 del that will enable innovative studies into Cryptosporidium biology and host interactions.

54 (hERG) activity of the first-generation anti-Cryptosporidium BKIs triggered further testing for effic

55 ve nearly identical in vitro potency against Cryptosporidium but display divergent PK properties.

56 cable to the study wells, wells positive for Cryptosporidium by IFA would likely be required to add t

57 45) were sampled ( n = 964) and analyzed for Cryptosporidium by qPCR and immunofluorescence assay (IF

58 Cryptosporidium cases were laboratory confirmed (by micr

59 Cryptosporidium causes significant diarrhea worldwide, e

60 The apicomplexan parasite Cryptosporidium causes significant diarrheal disease wor

61 We have shown that several BKIs of Cryptosporidium CDPK1 potently reduce enzymatic activity

62 Cryptosporidium chipmunk genotype I is an emerging zoono

63 Thus, Cryptosporidium chipmunk genotype I isolates from humans

64 C. andersoni, C. ubiquitum, C. tyzzeri, and Cryptosporidium chipmunk genotype I were processed with

65 s sporozoites directly into the intestine, a Cryptosporidium clustered regularly interspaced short pa

66 Cryptosporidium concentrations measured by qPCR and IFA

67 etting is expected to marginally reduce pond Cryptosporidium contamination (16%) while increasing loc

68 ementing 3-log10 inactivation conditions for Cryptosporidium (CT value = 15300 mg.min/L) to remediate

69 importance, including Eimeria, Sarcocystis, Cryptosporidium, Cyclospora, and Plasmodium species.

70 ance-based device is able to get insights on Cryptosporidium development on a cell culture and to qua

71 Strong protection was evident against Cryptosporidium diarrhea (cHR, 0.32; 95% CI, 0.20-0.51).

72 ectively for the isolation and enrichment of Cryptosporidium DNA from fecal specimens for whole-genom

73 the in vivo impact of P-glycoprotein on anti-Cryptosporidium efficacy.

74 ults indicate that SUB1 is a key mediator of Cryptosporidium egress and suggest that interruption of

75 Cryptosporidium emerged as a leading global cause of sev

76 rhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli produc

77 ova/parasite (O&P) examinations, and Giardia/Cryptosporidium enzyme immunoassay screens (GC-EIA) perf

78 Providing information about Cryptosporidium exposure during outdoor activities and i

79 ortant factors that determine the outcome of Cryptosporidium exposure.

80 sensor to detect different concentrations of Cryptosporidium, for which it is shown that the sample d

81 l method provides a novel means of silencing Cryptosporidium genes to study their role in host-parasi

82 Use of cryptosporidium genomes has helped to identify promising

83 ing sequence data covering 94.5% to 99.7% of Cryptosporidium genomes, with mostly minor contamination

84 ocedures for the isolation and enrichment of Cryptosporidium genomic DNA from fecal specimens and ver

85 proportion of positive colonies derived from Cryptosporidium genomic DNA, </=25%).

86 lla/enteroinvasive E. coli (EIEC), protozoa (Cryptosporidium, Giardia lamblia, and Entamoeba histolyt

87 ncrease in immunoglobulin G directed against Cryptosporidium gp15 and/or Cp23 antigens between consec

88 elopment for neglected tropical diseases for Cryptosporidium growth inhibitors identifies the 6-carbo

89 Cryptosporidium has a single-host life cycle in which bo

90 Cryptosporidium hominis (73.3%) was the predominant Cryp

91 d a preponderance of infections is caused by Cryptosporidium hominis and C. parvum.

92 unger age, longer duration of infection, and Cryptosporidium hominis gp60_IbA9G3R2 infection.

93 of compounds inhibit CpKRS and C. parvum and Cryptosporidium hominis in culture, and our lead compoun

94 eba histolytica, Cryptosporidium parvum, and Cryptosporidium hominis Similarly, these species cause t

95 obiotic piglets experimentally infected with Cryptosporidium hominis, the species responsible for >75

96 as inhibitors of Cryptosporidium parvum and Cryptosporidium hominis.

97 Although the mechanisms underlying Cryptosporidium-host cell interactions are not well unde

98 because the molecular mechanisms underlying Cryptosporidium-host cell interactions are poorly unders

99 y implicate a significant role for CpClec in Cryptosporidium-host cell interactions.

100 6; 1.6-4.1) in infants aged 0-11 months, and Cryptosporidium (HR 2.3; 1.3-4.3) in toddlers aged 12-23

101 ological experiments led us to conclude that Cryptosporidium imports purine nucleotides from the host

102 g more than 10,000 population to analyze for Cryptosporidium in at least 24 consecutive monthly sampl

103 native to hyperchlorination for inactivating Cryptosporidium in chlorinated recreational water venues

104 xide (ClO2) to achieve 2-log inactivation of Cryptosporidium in drinking water has been documented.

105 can be applied to determine transmission of Cryptosporidium in endemic regions.

106 le of predicting the presence of Giardia and Cryptosporidium in fresh surface waters in the Chicago a

107 he prediction of the presence of Giardia and Cryptosporidium in our location and were closely aligned

108 We determined the incidence of Cryptosporidium in PWS wells varying in surface water in

109 Recent rainfall increased the risk of Cryptosporidium in STWs (an extreme event) and ponds (an

110 %), with the largest increases predicted for Cryptosporidium in STWs.

111 are used to achieve a 3-log inactivation of Cryptosporidium in such venues.

112 andidate for treatment of diarrhea caused by Cryptosporidium in young children in the resource-limite

113 denovirus (in 29.1% and 2.7%, respectively), Cryptosporidium (in 27.8% and 8.2%, respectively), heat-

114 Currently, CYA's impact on Cryptosporidium inactivation is not fully determined.

115 Cryptosporidium incidence was not associated with surfac

116 the investigation of the process involved in Cryptosporidium-induced cell transformation.

117 Toxoplasma and Cryptosporidium infect millions of people each year with

118 We enrolled 48 case families with a Cryptosporidium-infected child aged 6-18 months.

119 th no apparent toxicity when administered to Cryptosporidium-infected interleukin 12 knockout mice at

120 Diagnostic tests for cryptosporidium infection are suboptimum, necessitating

121 -to-person transmission is a major source of Cryptosporidium infection for young children living in t

122 Here, we derive an in vivo model of Cryptosporidium infection in immunocompetent C57BL/6 mic

123 KDU731, a PI (4) kinase inhibitor, blocks Cryptosporidium infection in vitro and in vivo in immuno

124 ut the role of IL-18 in innate resistance to Cryptosporidium infection is unknown.

125 Recent studies have illustrated the burden Cryptosporidium infection places on the lives of malnour

126 Furthermore, a hollow fiber model of Cryptosporidium infection replicated the in vivo impact

127 r, end-stage liver disease caused by chronic Cryptosporidium infection required liver transplantation

128 Serologic response to Cryptosporidium infection was associated with younger ag

129 odel system capable of supporting continuous Cryptosporidium infection will be a useful tool for the

130 ct in vivo efficacy with a neonatal model of Cryptosporidium infection, these concentrations in the l

131 Despite the severity and global burden of Cryptosporidium infection, treatments are less than opti

132 ultiple in vitro models and a mouse model of Cryptosporidium infection, we characterized the effect o

133 fic gut microbial and biochemical effects of Cryptosporidium infection.

134 rther supported with an adult mouse model of Cryptosporidium infection.

135 cing (IP) gut microbiota on the outcome of a Cryptosporidium infection.

136 ay be relevant to host systemic responses to Cryptosporidium infection.

137 ultivation of PECs that can be used to study Cryptosporidium infection.

138 Cryptosporidium infections have been associated with gro

139 We found that average outbreak size of Cryptosporidium infections in sifakas was larger when th

140 uffering from recurrent bacterial, viral and Cryptosporidium infections, and identify a biallelic mut

141 of these enzymes as potential treatment for Cryptosporidium infections.

142 Cryptosporidium inosine 5'-monophosphate dehydrogenase (

143 Cryptosporidium is a genus of apicomplexan parasites, th

144 Infection with protozoa of the genus Cryptosporidium is a leading cause of child morbidity an

145 Cryptosporidium is a leading cause of diarrhea in small

146 Cryptosporidium is a leading cause of diarrheal disease

147 Cryptosporidium is a leading cause of moderate to severe

148 Cryptosporidium is a leading cause of pediatric diarrhea

149 Cryptosporidium is a leading contributor to diarrheal mo

150 The apicomplexan parasite Cryptosporidium is a leading global cause of severe diar

151 The apicomplexan parasite Cryptosporidium is a leading global cause of severe diar

152 The protozoan Cryptosporidium is a major public and animal health conc

153 Cryptosporidium is also an opportunistic pathogen in the

154 Cryptosporidium is emerging as 1 of the 4 leading diarrh

155 Understanding the environmental pathways of Cryptosporidium is essential for effective management of

156 Cryptosporidium is not uncommon in groundwater, even whe

157 Cryptosporidium is recognized as one of the main causes

158 ld-killer and famously recalcitrant parasite Cryptosporidium is the latest organism to yield to the m

159 Cryptosporidium is the main origin of worldwide waterbor

160 f mammals, and the CDPK1 of the apicomplexan Cryptosporidium lack side chains that typically block a

161 ing of parasite energy metabolism given that Cryptosporidium lacks oxidative phosphorylation and glyc

162 rehensive view of gene regulation during the Cryptosporidium life cycle will require the analysis of

163 esting of compounds in several stages of the Cryptosporidium life cycle.

164 Our results suggest that the Cryptosporidium lipid kinase PI(4)K (phosphatidylinosito

165 e literature, the hypothesis is offered that Cryptosporidium may be found in surface water anywhere w

166 Cryptosporidium might use as-yet undiscovered purine tra

167 e, discrimination of Cryptosporidium parvum, Cryptosporidium muris and Giardia lamblia, with over 92%

168 Through the ANOFEL Cryptosporidium National Network and the French Transpla

169 Controls were age- and sex-matched Cryptosporidium-negative children in 12 households.

170 c Escherichia coli, Shigella, Campylobacter, Cryptosporidium, norovirus GII, and adenovirus.

171 affect infection risks due to Campylobacter, Cryptosporidium, norovirus, and Vibrio.

172 hole, the data describe a spectrum of median Cryptosporidium occurrence in surface waters of the U.S.

173 While cryopreservation of Cryptosporidium oocysts by vitrification was recently ac

174 (-4) CFU of Vibrio cholerae, and <9 x 10(-6) Cryptosporidium oocysts per 100 mL.

175 levels of helminth eggs, Giardia cysts, and Cryptosporidium oocysts, but the UASB reactor system dis

176 ignificantly delays chlorine inactivation of Cryptosporidium oocysts, emphasizing the need for additi

177 collected before and after a challenge with Cryptosporidium oocysts.

178 fectious disease model to the 1993 Milwaukee Cryptosporidium outbreak, we demonstrate that environmen

179 emerged as a therapeutic target for treating Cryptosporidium parasites because it catalyzes a critica

180 Oral therapy with 1294 eliminated Cryptosporidium parasites from 6 of 7 infected severe co

181 Cryptosporidium parasites infect intestinal cells, causi

182 processes driving the complex life cycle of Cryptosporidium parasites, we analyzed the transcriptome

183 by lack of methods to genetically manipulate Cryptosporidium parasites.

184 chemical features and inhibitory kinetics of Cryptosporidium parvum ACSs using recombinant proteins.

185 ly by two species of apicomplexan parasites, Cryptosporidium parvum and C. hominis.

186 identify pyrazolopyridines as inhibitors of Cryptosporidium parvum and Cryptosporidium hominis.

187 effects of silver salt and nanoparticles on Cryptosporidium parvum and the removal of C. parvum by p

188 picomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.

189 Cryptosporidium parvum at various developmental stages w

190 sly, we identified and characterized a novel Cryptosporidium parvum C-type lectin domain-containing m

191 Bumped kinase inhibitors (BKIs) of Cryptosporidium parvum calcium-dependent protein kinase

192 rays (IMA's) during 76h and then infected by Cryptosporidium parvum during 60h.

193 In this study, 111 Cryptosporidium parvum IId isolates from several species

194 ition, the inhibitory potential of two known Cryptosporidium parvum IMPDH inhibitors was examined for

195 d- and liver-stage Plasmodium falciparum and Cryptosporidium parvum in cell-culture studies.

196 The half maximal effective concentration for Cryptosporidium parvum in HCT-8 cells was determined to

197 ntrolling enteric infection by the protozoan Cryptosporidium parvum in neonatal mice.

198 effect of short-term protein malnutrition on Cryptosporidium parvum infection in a murine model by ex

199 erstanding the protective immune response to Cryptosporidium parvum infection is of critical importan

200 We previously demonstrated that Cryptosporidium parvum infection stimulates host epithel

201 We used a piglet model of Cryptosporidium parvum infection to determine how elimin

202 reviously) to support long-term infection by Cryptosporidium parvum Infection was assessed by immunof

203 Cryptosporidium parvum is a major cause of diarrheal ill

204 Cryptosporidium parvum is an enteric protozoan parasite

205 Cryptosporidium parvum is an important opportunistic par

206 Cryptosporidium parvum is an opportunistic pathogen in A

207 surface charge heterogeneity on transport of Cryptosporidium parvum oocyst and carboxylate microspher

208 from pathogens such as Escherichia coli and Cryptosporidium parvum oocysts account for most of the c

209 Transport of Cryptosporidium parvum oocysts and microspheres in two d

210 Protein-deficient mice were infected with Cryptosporidium parvum oocysts for 6-13 days and compare

211 e and detect both Escherichia coli cells and Cryptosporidium parvum oocysts that have been embedded i

212 riments was performed with freshly harvested Cryptosporidium parvum oocysts to evaluate the effects o

213 human intestinal epithelial cells (HCT-8) by Cryptosporidium parvum resulted in a rapid induction of

214 We show that Cryptosporidium parvum splits into two subclades and tha

215 ge of newly available molecular genetics for Cryptosporidium parvum to investigate nucleotide biosynt

216 The hsp70 mRNA from Cryptosporidium parvum was used as a model analyte.

217 y Giardia duodenalis, Entamoeba histolytica, Cryptosporidium parvum, and Cryptosporidium hominis Simi

218 CDPK1 was cloned from the genome of Cryptosporidium parvum, and potent and specific inhibito

219 Altogether, 24 fecal specimens of Cryptosporidium parvum, C. hominis, C. andersoni, C. ubi

220 The three protozoan species Cryptosporidium parvum, C. meleagridis and C. hominis (p

221 Surprisingly, during infection by Cryptosporidium parvum, CCL20 production by the intestin

222 Furthermore, discrimination of Cryptosporidium parvum, Cryptosporidium muris and Giardi

223 eight enteropathogens (Giardia intestinalis, Cryptosporidium parvum, Entamoeba histolytica, Salmonell

224 idiosis, caused by the apicomplexan parasite Cryptosporidium parvum, is a diarrheal disease that has

225 7, has in vitro and in vivo efficacy against Cryptosporidium parvum.

226 ctive in both in vitro and in vivo models of Cryptosporidium parvum.

227 Despite its impact on human health, Cryptosporidium pathogenesis remains poorly known, mainl

228 eight wells (40%) and 107 samples (11%) were Cryptosporidium-positive by qPCR, and of these samples 6

229 However, silencing of NDK markedly inhibited Cryptosporidium proliferation (~70%).

230 human host and the population structures of Cryptosporidium remain unknown.

231 tic infection in immunocompromised patients, Cryptosporidium research has lagged due to a lack of fac

232 eer this parasite will be transformative for Cryptosporidium research.

233 ese studies represent a powerful toolbox for Cryptosporidium research.

234 ns parasitize within the host cell cytosols, Cryptosporidium resides on top of host cells, but it is

235 RNA (ssRNA), we induced specific slicing in Cryptosporidium RNA targets.

236 RBF on consumer health burdens for Giardia, Cryptosporidium, rotavirus, norovirus, and adenovirus in

237 ) threshold cycle (CT) values yielded mostly Cryptosporidium sequences in Sanger sequencing.

238 Giardia and Cryptosporidium shedding increased near large human popu

239 Norovirus GII, Cryptosporidium, Shigella, ST-ETEC, and adenovirus 40/41

240 ith the human enzyme Argonaute 2 (hAgo2) and Cryptosporidium single-stranded RNA (ssRNA), we induced

241 Cryptosporidium species are waterborne apicomplexan para

242 nd during diarrheal episodes were tested for Cryptosporidium species by polymerase chain reaction (PC

243 pisodes, and were tested for the presence of Cryptosporidium species by polymerase chain reaction.

244 nucleic acid test to detect the presence of Cryptosporidium species in DNA extracted from stool samp

245 rs, testing positive for either rotavirus or Cryptosporidium species in stool (coinfections were excl

246 the prevention of Entamoeba histolytica and Cryptosporidium species infection in children living in

247 es recurrent sinopulmonary, Pneumocystis and Cryptosporidium species infections.

248 ) is widely used to study gene function, but Cryptosporidium species lack the enzymes necessary to pr

249 parasiticidal, and potently inhibits the two Cryptosporidium species most relevant to human health, C

250 wing this strategy, 20 WGA products from six Cryptosporidium species or genotypes with low (mostly <1

251 Diarrhea associated with Cryptosporidium species tended to be longer in duration

252 poridium hominis (73.3%) was the predominant Cryptosporidium species, and there was no species-specif

253 For Cryptosporidium species, it had a sensitivity and specif

254 groups of pathogens: Campylobacter species, Cryptosporidium species, Shiga toxin-producing Escherich

255 herichia coli, norovirus GII, sapovirus, and Cryptosporidium species.

256 lasma immunoglobulin G, directed against the Cryptosporidium sporozoite-expressed antigen Cp23 at 12

257 Blastocystis hominis (1.03, 0.87-1.23), and Cryptosporidium spp (0.68, 0.17-2.68).

258 %, 0.4-6.3), astrovirus (2.7%, 2.2-3.1), and Cryptosporidium spp (2.0%, 1.3-2.6) exhibited the highes

259 Cryptosporidium spp are well recognised as causes of dia

260 0.99), G intestinalis (0.63, 0.50-0.80), and Cryptosporidium spp infections (0.83, 0.70-0.98).

261 enic E coli producing heat-stable toxin, and Cryptosporidium spp might substantially reduce the diarr

262 ths), and 0.5 versus 0.2 (24-59 months); for Cryptosporidium spp was 3.6 versus 2.3 (0-11 months), 4.

263 a spp, rotavirus, adenovirus 40/41, ST-ETEC, Cryptosporidium spp, and Campylobacter spp.

264 la spp (non-dysentery cases), Aeromonas spp, Cryptosporidium spp, and Entamoeba histolytica increased

265 ects but does not differentiate Giardia spp, Cryptosporidium spp, and Entamoeba histolytica, the Tri-

266 Campylobacter jejuni and Campylobacter coli, Cryptosporidium spp, enteropathogenic Escherichia coli,

267 cases of MSD and LSD were due to rotavirus, Cryptosporidium spp, enterotoxigenic Escherichia coli en

268 Cryptosporidium spp. are apicomplexan parasites of globa

269 o reuse simulation results are compared to a Cryptosporidium spp. database collected for the Long Ter

270 Whole-genome sequencing of Cryptosporidium spp. is hampered by difficulties in obta

271 l GloWPa-Crypto L1 calculates a total global Cryptosporidium spp. load from livestock manure of 3.2 x

272 In this paper we aim to quantify livestock Cryptosporidium spp. loads to land on a global scale usi

273 sinia enterocolitica, Entamoeba histolytica, Cryptosporidium spp., and E. coli O157:H7; 95% for Giard

274 dium difficile), parasites (Giardia lamblia, Cryptosporidium spp., and Entamoeba histolytica), and vi

275 Molecular characterization of Cryptosporidium spp., critical to epidemiological analys

276 O157), Shigella spp./enteroinvasive E. coli, Cryptosporidium spp., Cyclospora cayetanensis, Entamoeba

277 ped countries, including Giardia lamblia and Cryptosporidium spp., using technologies that, if expand

278 lia (syn. G. intestinalis/G. duodenalis) and Cryptosporidium spp., using technologies that, if expand

279 ceptible-exposed-infected-recovered model of Cryptosporidium spread in wild Verreaux's sifakas.

280 In this study, we characterized Cryptosporidium SUB1 expression and evaluated its effect

281 introgression between the four anthroponotic Cryptosporidium subtypes and species included in this st

282 Genetic exchange between Cryptosporidium subtypes plays a prominent role througho

283 icomplexan intestinal parasites of the genus Cryptosporidium take a major toll on human and animal he

284 pharmacokinetic characteristics of new anti-Cryptosporidium therapeutics.

285 logical studies found the protozoan parasite Cryptosporidium to be a leading cause of paediatric diar

286 s indole alone, can influence the ability of Cryptosporidium to establish an infection.

287 Here, we genetically engineered strains of Cryptosporidium to make life cycle progression and paras

288 n parasites, such as Plasmodium, Toxoplasma, Cryptosporidium, trypanosomes, and Leishmania, are a maj

289 ive pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can su

290 Groundwater is assumed free of Cryptosporidium unless surface water is entering supply

291 s and genotypes can infect humans, including Cryptosporidium viatorum, which, to date, has only been

292 ctions were mainly asymptomatic (693 [66%]), Cryptosporidium was identified in 9.4% of diarrheal epis

293 Cryptosporidium was not found in any sample.

294 In the required sample volumes of 10 L no Cryptosporidium were found in 86% of samples and no Giar

295 No Cryptosporidium were found in 93% of samples and no Cryp

296 poridium were found in 93% of samples and no Cryptosporidium were found in any samples analyzed from

297 tions representing every region of the U.S., Cryptosporidium were found in sufficient numbers of samp

298 arasites such as Plasmodium, Toxoplasma, and Cryptosporidium, which are causing severe health and eco

299 ate developmental progression towards sex in Cryptosporidium, which has important implications for th

300 system supporting the complete life cycle of Cryptosporidium, while Sateriale et al. (2019) report an